| Year |
Citation |
Score |
| 2020 |
Kunos CA, Rubinstein LV, Capala J, McDonald MA. Phase 0 Radiopharmaceutical-Agent Clinical Development. Frontiers in Oncology. 10: 1310. PMID 33014772 DOI: 10.3389/Fonc.2020.01310 |
0.36 |
|
| 2020 |
Small W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, et al. NRG Oncology /RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update. International Journal of Radiation Oncology, Biology, Physics. PMID 32905846 DOI: 10.1016/J.Ijrobp.2020.08.061 |
0.313 |
|
| 2020 |
Kunos CA, Abdallah R. Financial Toxicity Encountered in Therapeutic Radiopharmaceutical Clinical Development for Ovarian Cancer. Pharmaceuticals (Basel, Switzerland). 13. PMID 32764223 DOI: 10.3390/Ph13080181 |
0.42 |
|
| 2020 |
Myint ZW, Kunos CA. Bone Fracture Incidence After Androgen Deprivation Therapy-Investigational Agents: Results From Cancer Therapy Evaluation Program-Sponsored Early Phase Clinical Trials 2006-2013. Frontiers in Oncology. 10: 1125. PMID 32760670 DOI: 10.3389/Fonc.2020.01125 |
0.346 |
|
| 2020 |
Chauhan A, Kabir T, Wu J, Wei J, Cook M, Kunos CA. Prognostic and predictive factors associated with ipilimumab-related adverse events: a retrospective analysis of 11 NCI-sponsored phase I clinical trials. Oncotarget. 11: 1427-1434. PMID 32363000 DOI: 10.18632/Oncotarget.27537 |
0.318 |
|
| 2020 |
Kunos C, Ferris G, Waggoner S. Implementing chemoradiation treatment for patients with cervical cancer in a comprehensive cancer center community oncology practice. Community Oncology. 7: 446-450. PMID 31723339 |
0.373 |
|
| 2020 |
Biswas T, Dowlati A, Kunos C, Pink J, Oleinick N, Malik SM, Fu P, Bruno DS, Bajor DL, Patel M, Machtay M. Base excision repair (BER) inhibitor TRC 102 (Methoxyamine) combined with pemetrexed (PEM)-based chemo-radiation (CRT) for locally advanced non-squamous non-small cell lung cancer (NS-NSCLC): Results of a phase I trial. Journal of Clinical Oncology. 38: 9027-9027. DOI: 10.1200/Jco.2020.38.15_Suppl.9027 |
0.388 |
|
| 2020 |
Rychahou P, Chauhan A, Chow Z, Izumi T, Chen Q, Lee EY, Napier D, Anthony LB, Cavnar MJ, Kunos C, Evers BM. Abstract 6402: DNA-PK inhibitor, M3814, as a radiation sensitizer in the treatment of neuroendocrine tumors Cancer Research. 80: 6402-6402. DOI: 10.1158/1538-7445.Am2020-6402 |
0.372 |
|
| 2019 |
Kunos CA, Andrews SJ, Moore KN, Chon HS, Ivy SP. Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers. Frontiers in Oncology. 9: 1067. PMID 31681600 DOI: 10.3389/Fonc.2019.01067 |
0.438 |
|
| 2019 |
Kunos CA, Capala J, Dicker AP, Movsas B, Ivy SP, Minasian LM. Clinical Outcome Assessments Toolbox for Radiopharmaceuticals. Frontiers in Oncology. 9: 1028. PMID 31649885 DOI: 10.3389/Fonc.2019.01028 |
0.331 |
|
| 2019 |
Ivy SP, Kunos CA, Arnaldez FI, Kohn EC. Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints. Expert Opinion On Investigational Drugs. 28: 771-785. PMID 31449760 DOI: 10.1080/13543784.2019.1657403 |
0.375 |
|
| 2019 |
Kinsella TJ, Safran H, Wiersma SR, DiPetrillo T, Schumacher A, Rosati K, Vatkevich J, Anderson LW, Hill K, Kunos CA, Collins JM. Phase I and Pharmacology study of Ropidoxuridine (IPdR) as prodrug for iododeoxyuridine-mediated tumor radiosensitization in advanced GI cancer undergoing radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31337643 DOI: 10.1158/1078-0432.Ccr-19-0862 |
0.476 |
|
| 2019 |
Kunos CA, Capala J, Kohn EC, Ivy SP. Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer. Frontiers in Oncology. 9: 560. PMID 31297338 DOI: 10.3389/Fonc.2019.00560 |
0.431 |
|
| 2019 |
Kunos CA, Ivy P. Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Brachytherapy in Puerto Rico After Hurricane Maria. Frontiers in Oncology. 9: 414. PMID 31157171 DOI: 10.3389/Fonc.2019.00414 |
0.379 |
|
| 2019 |
Kunos CA, Capala J, Finnigan S, Smith GL, Ivy SP. Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers. Frontiers in Oncology. 9: 180. PMID 30984615 DOI: 10.3389/Fonc.2019.00180 |
0.436 |
|
| 2019 |
Kunos CA, Capala J, Ivy SP. Radiopharmaceuticals for Relapsed or Refractory Leukemias. Frontiers in Oncology. 9: 97. PMID 30859091 DOI: 10.3389/Fonc.2019.00097 |
0.378 |
|
| 2019 |
Kizilbash SH, McBrayer S, Port J, Reid JM, Lanza I, Allred JB, Chakravarti A, Kunos C, Adjei AA. A phase Ib trial of CB-839 (telaglenastat) in combination with radiation therapy and temozolomide in patients with IDH-mutated diffuse astrocytoma and anaplastic astrocytoma (NCT03528642). Journal of Clinical Oncology. 37: TPS2075-TPS2075. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps2075 |
0.382 |
|
| 2019 |
Chauhan A, Rychahou P, Izumi T, Arnold SM, Anthony LB, Evers M, Kunos C. Antitumor efficacy of M3814 as a radiation sensitizer in neuroendocrine tumor (NET) preclinical models. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E15699 |
0.343 |
|
| 2019 |
Kizilbash SH, Burgenske DM, McBrayer S, Devarajan S, Gupta SK, Hitosugi T, He L, Schroeder MA, Carlson BL, Gelman M, Kunos CA, Reid JM, Adjei AA, Sarkaria JN. Abstract 3870: The addition of CB-839 to temozolomide significantly reduces glioma aspartate and glutamate in an IDH mutated patient derived glioma xenograft model Cancer Research. 79: 3870-3870. DOI: 10.1158/1538-7445.Sabcs18-3870 |
0.319 |
|
| 2018 |
Kunos CA, Capala J. National Cancer Institute Programmatic Collaboration for Investigational Radiopharmaceuticals. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 488-494. PMID 30231365 DOI: 10.1200/EDBK_200199 |
0.302 |
|
| 2018 |
Boardman CH, Brady WE, Dizon DS, Kunos CA, Moore KN, Zanotti KM, Matthews C, Cosin JA, Aghajanian C, Fracasso PM. A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologic Oncology Group Study. Gynecologic Oncology. PMID 30174176 DOI: 10.1016/J.Ygyno.2018.08.006 |
0.41 |
|
| 2018 |
Kunos CA, Ivy SP. Triapine Radiochemotherapy in Advanced Stage Cervical Cancer. Frontiers in Oncology. 8: 149. PMID 29868473 DOI: 10.3389/Fonc.2018.00149 |
0.487 |
|
| 2018 |
Kunos CA, Massett HA, Galassi A, Walker JL, Good MJ, Díaz LB, McCaskill-Stevens W. Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Patient Accrual in Puerto Rico. Frontiers in Oncology. 8: 102. PMID 29692980 DOI: 10.3389/Fonc.2018.00102 |
0.403 |
|
| 2018 |
Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM. Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop. Journal For Immunotherapy of Cancer. 6: 6. PMID 29375032 DOI: 10.1186/S40425-018-0317-Y |
0.359 |
|
| 2018 |
Kunos CA, Coleman CN. Current and Future Initiatives for Radiation Oncology at the National Cancer Institute in the Era of Precision Medicine. International Journal of Radiation Oncology, Biology, Physics. PMID 29325810 DOI: 10.1016/J.Ijrobp.2017.02.225 |
0.412 |
|
| 2017 |
Kunos CA, Kohn EC. Editorial: New Approaches to Radiation-Therapeutic Agent Cancer Care for Women. Frontiers in Oncology. 7: 276. PMID 29473016 DOI: 10.3389/Fonc.2017.00276 |
0.374 |
|
| 2017 |
Kunos CA, Chu E, Makower D, Kaubisch A, Sznol M, Ivy SP. Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers. Frontiers in Oncology. 7: 62. PMID 28421163 DOI: 10.3389/Fonc.2017.00062 |
0.391 |
|
| 2016 |
Kunos CA. Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer. Frontiers in Oncology. 6: 263. PMID 28066719 DOI: 10.3389/fonc.2016.00263 |
0.312 |
|
| 2015 |
Kunos CA, Olszewski S, Espinal E. Impact of nurse navigation on timeliness of diagnostic medical services in patients with newly diagnosed lung cancer. The Journal of Community and Supportive Oncology. 13: 219-24. PMID 26270521 DOI: 10.12788/Jcso.0141 |
0.301 |
|
| 2015 |
Kunos CA, Fabien JM, Shanahan JP, Collen C, Gevaert T, Poels K, Van den Begin R, Engels B, De Ridder M. Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy. Journal of Visualized Experiments : Jove. e52875. PMID 26131774 DOI: 10.3791/52875 |
0.408 |
|
| 2015 |
Kunos CA, Sherertz TM, Mislmani M, Ellis RJ, Lo SS, Waggoner SE, Zanotti KM, Herrmann K, Debernardo RL. Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer. Frontiers in Oncology. 5: 126. PMID 26097831 DOI: 10.3389/Fonc.2015.00126 |
0.435 |
|
| 2015 |
Kunos C, Deng W, Dawson D, Lea JS, Zanotti KM, Gray HJ, Bender DP, Guaglianone PP, Carter JS, Moore KN. A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 25: 484-92. PMID 25594147 DOI: 10.1097/Igc.0000000000000380 |
0.431 |
|
| 2015 |
Kunos CA, Shanahan JP. 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Definition of Lung Targets in Vero Stereotactic Body Radiation Therapy Workflow Journal of Nuclear Medicine and Radiation Therapy. 6. DOI: 10.4172/2155-9619.1000227 |
0.314 |
|
| 2014 |
Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, et al. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 90: 320-8. PMID 25304792 DOI: 10.1016/J.Ijrobp.2014.06.005 |
0.328 |
|
| 2014 |
Kunos CA, Sherertz TM. Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer. Frontiers in Oncology. 4: 184. PMID 25105092 DOI: 10.3389/Fonc.2014.00184 |
0.419 |
|
| 2014 |
Mislmani M, Frasure H, Suppiah S, Fabien J, Lo SS, Debernardo R, Kunos CA. Acute gastrointestinal toxicity after robotic stereotactic ablative radiotherapy for treatment of metastatic gynecological malignancies. Future Oncology (London, England). 10: 241-8. PMID 24490610 DOI: 10.2217/Fon.13.215 |
0.382 |
|
| 2014 |
Olsen JR, Moughan J, Myerson RJ, Abitbol A, Kunos C, Johnson D, Schefter T, Chen Y, Fisher BJ, Michalski JM, Narayan S, Chang A, Crane CH, Kachnic LA. Predictors of radiotherapy-related gastrointestinal toxicity from anal cancer DP-IMRT: Secondary analysis of RTOG 0529. Journal of Clinical Oncology. 32: 460-460. DOI: 10.1200/Jco.2014.32.3_Suppl.460 |
0.417 |
|
| 2014 |
Mislmani M, Sherertz TM, Waggoner S, Zanotti K, Resnick K, Lo SS, Ellis RJ, Machtay M, DeBernardo R, Kunos C. Concurrent Carboplatin and Gemcitabine With SBRT for Persistent or Recurrent Gynecological Cancers: A Phase 1 Trial International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.716 |
0.353 |
|
| 2014 |
Olsen JR, Moughan J, Myerson RJ, Abitbol AA, Kunos C, Johnson DW, Schefter T, Chen Y, Fisher B, Michalski J, Narayan S, Chang AJ, Crane CH, Kachnic LA. Predictors of Radiotherapy-Related GI Toxicity from Anal Cancer DP-IMRT: Secondary Analysis of RTOG 0529 International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.138 |
0.416 |
|
| 2013 |
Weinberg LE, Kunos CA, Zanotti KM. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 1438-45. PMID 24257558 DOI: 10.1097/Igc.0B013E3182A16C93 |
0.322 |
|
| 2013 |
Kunos CA, Stefan T, Jacobberger JW. Cabazitaxel-induced stabilization of microtubules enhances radiosensitivity in ovarian cancer cells. Frontiers in Oncology. 3: 226. PMID 24066277 DOI: 10.3389/Fonc.2013.00226 |
0.387 |
|
| 2013 |
Kunos CA, Spelic M. Role of stereotactic radiosurgery in gynecologic cancer. Current Opinion in Oncology. 25: 532-8. PMID 23942297 DOI: 10.1097/CCO.0b013e328363e0ad |
0.344 |
|
| 2013 |
Kunos CA, Radivoyevitch T, Waggoner S, Debernardo R, Zanotti K, Resnick K, Fusco N, Adams R, Redline R, Faulhaber P, Dowlati A. Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers. Gynecologic Oncology. 130: 75-80. PMID 23603372 DOI: 10.1016/J.Ygyno.2013.04.019 |
0.422 |
|
| 2013 |
Berber B, Sanabria JR, Braun K, Yao M, Ellis RJ, Kunos CA, Sohn J, Machtay M, Teh BS, Huang Z, Mayr NA, Lo SS. Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer. Expert Review of Anticancer Therapy. 13: 481-7. PMID 23560842 DOI: 10.1586/Era.13.19 |
0.465 |
|
| 2013 |
Kunos CA, Winter K, Dicker AP, Small W, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK. Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 615-21. PMID 23552804 DOI: 10.1097/Igc.0B013E31828B4Eb5 |
0.402 |
|
| 2013 |
Shunkwiler L, Ferris G, Kunos C. Inhibition of Poly(ADP-Ribose) Polymerase Enhances Radiochemosensitivity in Cancers Proficient in DNA Double-Strand Break Repair International Journal of Molecular Sciences. 14: 3773-3785. PMID 23396107 DOI: 10.3390/Ijms14023773 |
0.404 |
|
| 2013 |
Simpkins F, Papadia A, Kunos C, Michener C, Frasure H, AbuShahin F, Mariani A, Bakkum-Gamez JN, Landrum L, Moore K, Thomas SG, Windhorn A, Rose PG. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 98-104. PMID 23221731 DOI: 10.1097/Igc.0B013E318276D9B6 |
0.435 |
|
| 2013 |
Weinberg L, Kunos C, Zanotti K. Lymphadenectomy in women with early-stage intermediate-to high-risk endometrial cancer (HIR-EC) decreases local recurrence but not overall recurrence or survival: A retrospective cohort study Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.223 |
0.375 |
|
| 2013 |
Kunos C, Brindle J, Singh S, Pettigrew G, DeBernardo R. Phase II trial of robotic cyberknife radiation therapy in patients with recurrent gynecological malignancies Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.079 |
0.373 |
|
| 2013 |
Mislmani M, Suppiah S, Frasure H, Lo S, Debernardo R, Kunos C. Gastrointestinal Toxicity After Robotic Stereotactic Ablative Radiation Therapy (SABR) for Treatment of Metastatic Gynecologic Malignancies International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1122 |
0.362 |
|
| 2012 |
Kunos CA, Brindle J, Waggoner S, Zanotti K, Resnick K, Fusco N, Adams R, Debernardo R. Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies. Frontiers in Oncology. 2: 181. PMID 23227452 DOI: 10.3389/Fonc.2012.00181 |
0.375 |
|
| 2012 |
Kunos CA, Radivoyevitch T, Kresak A, Dawson D, Jacobberger J, Yang B, Abdul-Karim FW. Elevated ribonucleotide reductase levels associate with suppressed radiochemotherapy response in human cervical cancers. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 22: 1463-9. PMID 23051959 DOI: 10.1097/Igc.0B013E318270577F |
0.409 |
|
| 2012 |
Kunos CA. Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer. Oncology & Hematology Review. 8: 55-60. PMID 22943045 |
0.302 |
|
| 2012 |
Kunos C, Brindle JM, Debernardo R. Stereotactic radiosurgery for gynecologic cancer. Journal of Visualized Experiments : Jove. PMID 22546879 DOI: 10.3791/3793 |
0.441 |
|
| 2012 |
Kunos C, Radivoyevitch T, Abdul-Karim FW, Fanning J, Abulafia O, Bonebrake AJ, Usha L. Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study. Journal of Translational Medicine. 10: 79. PMID 22541066 DOI: 10.1186/1479-5876-10-79 |
0.335 |
|
| 2012 |
Choe J, Kulasekere R, Oddo D, Anthony S, Shin T, Murray M, Kunos CA. Helical tomotherapy versus conventional radiation to deliver abdominopelvic radiation. Technology in Cancer Research & Treatment. 11: 49-56. PMID 22181331 DOI: 10.7785/Tcrt.2012.500234 |
0.461 |
|
| 2012 |
Chao J, Synold TW, Morgan RJ, Kunos C, Longmate J, Lenz HJ, Lim D, Shibata S, Chung V, Stoller RG, Belani CP, Gandara DR, McNamara M, Gitlitz BJ, Lau DH, et al. A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. Cancer Chemotherapy and Pharmacology. 69: 835-43. PMID 22105720 DOI: 10.1007/S00280-011-1779-5 |
0.389 |
|
| 2012 |
Goyal K, Einstein D, Ibarra RA, Yao M, Kunos C, Ellis R, Brindle J, Singh D, Hardacre J, Zhang Y, Fabians J, Funkhouser G, Machtay M, Sanabria JR. Stereotactic body radiation therapy for nonresectable tumors of the pancreas. The Journal of Surgical Research. 174: 319-25. PMID 21937061 DOI: 10.1016/J.Jss.2011.07.044 |
0.381 |
|
| 2012 |
Kunos C, Brindle J, Adams R, DeBernardo R. Phase II trial of robotic stereotactic radiosurgery (SBRT) in patients with recurrent gynecologic malignancies. Journal of Clinical Oncology. 30: 5102-5102. DOI: 10.1200/Jco.2012.30.15_Suppl.5102 |
0.435 |
|
| 2012 |
Weinberg LE, Zanotti KM, Kunos C. Association of smoking with pulmonary recurrences among women with intermediate- to high-risk early-stage endometrial adenocarcinoma. Journal of Clinical Oncology. 30: 5089-5089. DOI: 10.1200/Jco.2012.30.15_Suppl.5089 |
0.331 |
|
| 2012 |
Kunos C, Winter K, Dicker A, Small W, Abdul-Karim F, Dawson D, Jhingran A, Valicenti R, Weidhaas J, Gaffney D. RTOG 0116 and 0128: Secondary analysis of ribonucleotide reductase in cervix cancer Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.104 |
0.366 |
|
| 2012 |
Ellis RJ, Patel RB, Kunos C, Zhang Y, Brindle J, Kudithipudi V, Kaminsky DA, Ponsky L. Stereotactic Radiosurgery for Renal Cancer: Phase I Safety and Toxicity International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.209 |
0.342 |
|
| 2012 |
Siddiqui F, Kunos CA, Paulino AC. Stereotactic body radiation therapy in head and neck, gynecologic, and pediatric malignancies Journal of Radiation Oncology. 1: 31-42. DOI: 10.1007/S13566-012-0009-Z |
0.428 |
|
| 2011 |
Kunos C, Waggoner SE, Zanotti KM, DeBernardo R, Fusco N, Heugel A, Knazek J, Adams R, Radivoyevitch T, Dowlati A. Phase II trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical and vaginal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5034. PMID 28023711 DOI: 10.1200/Jco.2011.29.15_Suppl.5034 |
0.439 |
|
| 2011 |
Kunos CA, Debernardo R, Fabien J, Dobbins DC, Zhang Y, Brindle J, Faulhaber PF. (18)FDG-PET/CT Definition of Clinical Target Volume for Robotic Stereotactic Body Radiosurgery Treatment of Metastatic Gynecologic Malignancies. Journal of Nuclear Medicine & Radiation Therapy. PMID 25506042 DOI: 10.4172/2155-9619.S4-001 |
0.315 |
|
| 2011 |
Kunos CA, Radivoyevitch T. Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies. Gynecology & Obstetrics (Sunnyvale, Calif.). 001. PMID 25392744 DOI: 10.4172/2161-0932.S4-001 |
0.353 |
|
| 2011 |
Schwandt A, Chen WC, Martra F, Zola P, Debernardo R, Kunos CA. Chemotherapy plus radiation in advanced-stage endometrial cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 21: 1622-7. PMID 21897269 DOI: 10.1097/Igc.0B013E31822B6594 |
0.452 |
|
| 2011 |
Mayr NA, Huang Z, Sohn JW, Lo SS, Teh BS, Lu JJ, Grecula JC, Kunos C. Emerging application of stereotactic body radiation therapy for gynecologic malignancies. Expert Review of Anticancer Therapy. 11: 1069-75. PMID 21806330 DOI: 10.1586/Era.11.81 |
0.469 |
|
| 2011 |
Kunos C, Radivoyevitch T, Abdul-Karim FW, Faulhaber P. 18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 21: 1117-23. PMID 21792015 DOI: 10.1097/Igc.0B013E31821Dc8B5 |
0.302 |
|
| 2011 |
Kunos CA, Ferris G, Pyatka N, Pink J, Radivoyevitch T. Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers. Radiation Research. 176: 425-33. PMID 21756082 DOI: 10.1667/Rr2556.1 |
0.326 |
|
| 2011 |
Kunos CA, Colussi VC, Pink J, Radivoyevitch T, Oleinick NL. Radiosensitization of human cervical cancer cells by inhibiting ribonucleotide reductase: enhanced radiation response at low-dose rates. International Journal of Radiation Oncology, Biology, Physics. 80: 1198-204. PMID 21470790 DOI: 10.1016/J.Ijrobp.2011.01.034 |
0.409 |
|
| 2011 |
Kunos C, Woods C, Colussi VC, Abdul-Karim FW, Waggoner S. Low-dose-rate brachytherapy for treatment of uterine didelphys malignancy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e104-6. PMID 21098325 DOI: 10.1200/Jco.2010.31.7545 |
0.316 |
|
| 2011 |
Kunos CA, Sill MW, Buekers TE, Walker JL, Schilder JM, Yamada SD, Waggoner SE, Mohiuddin M, Fracasso PM. Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group. Gynecologic Oncology. 120: 224-8. PMID 21075438 DOI: 10.1016/J.Ygyno.2010.10.018 |
0.454 |
|
| 2011 |
Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos CA. Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. International Journal of Radiation Oncology, Biology, Physics. 80: 751-7. PMID 20619551 DOI: 10.1016/J.Ijrobp.2010.02.058 |
0.389 |
|
| 2011 |
Zheng Y, Zhang Y, Brindle J, Fabien J, Chen W, Woods C, Galanopoulos N, Choe J, Kunos C, Ellis RJ, Ponsky LEMC, Funkhouser G, Machtay M, Einstein D, Wessels BW. SU‐E‐T‐644: Software Tool Used in Setting Optimization Control Points for Hypofractionated CyberKnife Treatment Planning Medical Physics. 38: 3638-3638. DOI: 10.1118/1.3612607 |
0.376 |
|
| 2010 |
Kunos CA, Radivoyevitch T, Pink J, Chiu SM, Stefan T, Jacobberger J, Kinsella TJ. Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers. Radiation Research. 174: 574-81. PMID 20954859 DOI: 10.1667/Rr2273.1 |
0.359 |
|
| 2010 |
Goyal K, Einstein D, Yao M, Kunos C, Barton F, Singh D, Siegel C, Stulberg J, Sanabria J. Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results. Hpb Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery. 2010. PMID 20689733 DOI: 10.1155/2010/309780 |
0.365 |
|
| 2010 |
Kunos C, Ali S, Abdul-Karim FW, Stehman FB, Waggoner S. Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study. American Journal of Obstetrics and Gynecology. 203: 351.e1-8. PMID 20541170 DOI: 10.1016/J.Ajog.2010.05.005 |
0.396 |
|
| 2010 |
Kunos CA, Waggoner S, von Gruenigen V, Eldermire E, Pink J, Dowlati A, Kinsella TJ. Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1298-306. PMID 20145183 DOI: 10.1158/1078-0432.Ccr-09-2469 |
0.427 |
|
| 2010 |
Rasool N, Fader AN, Seamon L, Neubauer NL, Shahin FA, Alexander HA, Moore K, Moxley K, Secord AA, Kunos C, Rose PG, O'Malley DM. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence. Gynecologic Oncology. 116: 10-4. PMID 19875158 DOI: 10.1016/J.Ygyno.2009.10.043 |
0.359 |
|
| 2010 |
Kunos C, Ferris G, Waggoner S. Implementing chemoradiation treatment for patients with cervical cancer in a comprehensive cancer center community oncology practice. Community Oncology. 7: 446-450. DOI: 10.1016/S1548-5315(11)70424-7 |
0.469 |
|
| 2009 |
Kunos CA, Chiu SM, Pink J, Kinsella TJ. Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein. Radiation Research. 172: 666-76. PMID 19929413 DOI: 10.1667/Rr1858.1 |
0.411 |
|
| 2009 |
Kunos C, Tian C, Waggoner S, Rose PG, Lanciano R. Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group study. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 1258-63. PMID 19823064 DOI: 10.1111/Igc.0B013E3181B33Ace |
0.393 |
|
| 2009 |
Kunos C, Chen W, DeBernardo R, Waggoner S, Brindle J, Zhang Y, Williams J, Einstein D. Stereotactic Body Radiosurgery for Pelvic Relapse of Gynecologic Malignancies Technology in Cancer Research & Treatment. 8: 393-400. PMID 19754216 DOI: 10.1177/153303460900800510 |
0.44 |
|
| 2009 |
Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstetrics and Gynecology. 114: 537-46. PMID 19701032 DOI: 10.1097/Aog.0B013E3181B12F99 |
0.421 |
|
| 2009 |
Goksedef BPC, Kunos C, Belinson JL, Rose PG. Concurrent cisplatin-based chemoradiation International Federation of Gynecology and Obstetrics stage IB2 cervical carcinoma. American Journal of Obstetrics and Gynecology. 200: 175-177. PMID 19091305 DOI: 10.1016/J.Ajog.2008.08.055 |
0.393 |
|
| 2009 |
Choe J, Kulasekere R, Oddo D, Anthony S, Shin T, Kunos C. Novel Method for Delivering Highly Conformal Whole Abdominal Irradiation with Helical Tomotherapy International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.864 |
0.421 |
|
| 2008 |
Zagar TM, Shenk RR, Kim JA, Harpp D, Kunos CA, Abdul-Karim FW, Chen WC, Seo Y, Kinsella TJ. Radiation therapy in addition to gross total resection of retroperitoneal sarcoma results in prolonged survival: results from a single institutional study. Journal of Oncology. 2008: 824036. PMID 19277103 DOI: 10.1155/2008/824036 |
0.42 |
|
| 2008 |
Kunos C, Gibbons H, Simpkins F, Waggoner S. Chemotherapy Administration during Pelvic Radiation for Cervical Cancer Patients Aged >/=55 Years in the SEER-Medicare Population. Journal of Oncology. 2008: 931532-931532. PMID 19259335 DOI: 10.1155/2008/931532 |
0.412 |
|
| 2008 |
Kunos C, von Gruenigen V, Waggoner S, Brindle J, Zhang Y, Myers B, Funkhouser G, Wessels B, Einstein D. Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapy. Technology in Cancer Research & Treatment. 7: 375-80. PMID 18783287 DOI: 10.1177/153303460800700504 |
0.463 |
|
| 2008 |
Kunos CA, Dobbins DC, Kulasekere R, Latimer B, Kinsella TJ. Comparison of helical tomotherapy versus conventional radiation to deliver craniospinal radiation. Technology in Cancer Research & Treatment. 7: 227-33. PMID 18473494 DOI: 10.1177/153303460800700308 |
0.614 |
|
| 2008 |
Martra F, Kunos C, Gibbons H, Zola P, Galletto L, DeBernardo R, Gruenigen Vv. Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study. American Journal of Obstetrics and Gynecology. 198: 89-91. PMID 18166317 DOI: 10.1016/J.Ajog.2007.06.023 |
0.362 |
|
| 2008 |
Simpkins F, Kunos C, Mariani A, Bakkum-Gamez J, Landrum L, Moore K, Michener C, Rose PG. Impact of adjuvant radiation therapy (RT) on recurrence and survival outcomes in stage IB-IIA endometrial cancer (EMCA) patients with lymph vascular invasion (LVSI) Journal of Clinical Oncology. 26: 5568-5568. DOI: 10.1200/Jco.2008.26.15_Suppl.5568 |
0.401 |
|
| 2008 |
Goksedef BP, Kunos C, Belinson J, Rose PG. Concurrent cisplatin-based chemoradiation for figo stage 1b2 cervical carcinoma Journal of Clinical Oncology. 26: 16595-16595. DOI: 10.1200/Jco.2008.26.15_Suppl.16595 |
0.414 |
|
| 2006 |
Kunos C, Latson L, Overmoyer B, Silverman P, Shenk R, Kinsella T, Lyons J. Breast Conservation Surgery Achieving ≥ 2 mm Tumor-Free Margins Results in Decreased Local-Regional Recurrence Rates Breast Journal. 12: 28-36. PMID 16409584 DOI: 10.1111/J.1075-122X.2006.00181.X |
0.354 |
|
| 2006 |
Kunos C, Martra F, Frasure H, Zola P, Waggoner S, Gruenigen Vv. 2359 : Retrospective Comparison of Surgical and Radiation Treatment in Early Stage Endometrial Cancer in the United States and Italy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.768 |
0.401 |
|
| Show low-probability matches. |